Lori M. Laffel

36.3k total citations · 9 hit papers
309 papers, 17.4k citations indexed

About

Lori M. Laffel is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Lori M. Laffel has authored 309 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 275 papers in Endocrinology, Diabetes and Metabolism, 113 papers in Surgery and 99 papers in Genetics. Recurrent topics in Lori M. Laffel's work include Diabetes Management and Research (257 papers), Pancreatic function and diabetes (111 papers) and Diabetes and associated disorders (99 papers). Lori M. Laffel is often cited by papers focused on Diabetes Management and Research (257 papers), Pancreatic function and diabetes (111 papers) and Diabetes and associated disorders (99 papers). Lori M. Laffel collaborates with scholars based in United States, Germany and United Kingdom. Lori M. Laffel's co-authors include Barbara J. Anderson, Lisa K. Volkening, Anne L. Peters, Deborah Butler, Korey K. Hood, James H. Warram, Julienne Brackett, Jessica T. Markowitz, Jane L. Chiang and A S Krolewski and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Lori M. Laffel

289 papers receiving 16.6k citations

Hit Papers

Ketone bodies: a review of physiology, pathophysiology an... 1988 2026 2000 2013 1999 2005 2014 1988 2011 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes
    1999 1.0k citations Lori M. Laffel profile →
  2. Care of Children and Adolescents With Type 1 Diabetes
    2005 989 citations Lori M. Laffel, Barbara J. Anderson et al. Diabetes Care profile →
  3. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
    2014 656 citations Lori M. Laffel et al. Diabetes Care profile →
  4. Predisposition to Hypertension and Susceptibility to Renal Disease in Insulin-Dependent Diabetes Mellitus
    1988 493 citations Lori M. Laffel et al. profile →
  5. Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems
    2011 437 citations Lori M. Laffel et al. Diabetes Care profile →
  6. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association
    2018 311 citations Korey K. Hood, Lori M. Laffel et al. Diabetes Care profile →
  7. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes
    2020 268 citations Lori M. Laffel, Lauren Kanapka et al. profile →
  8. Empagliflozin as Adjunctive to Insulin Therapy in Type 1 Diabetes: The EASE Trials
    2018 244 citations Jan Marquard, Lori M. Laffel et al. Diabetes Care profile →
  9. Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Persist in People With Type 1 Diabetes Despite Use of Diabetes Technology: Results From a Cross-sectional Survey
    2024 42 citations Jennifer L. Sherr, Lori M. Laffel et al. Diabetes Care profile →

Peers

Lori M. Laffel
Comparison fields: 5 of 175
  • Endocrinology, Diabetes and Metabolism 12.3k
  • Genetics 5.3k
  • Surgery 5.0k
  • Speech and Hearing 3.2k
  • Pediatrics, Perinatology and Child Health 2.8k
Replace Giuseppina Imperatore with:
Giuseppina Imperatore United States
David M. Maahs United States
Lawrence M. Dolan United States
Reinhard W. Holl Germany
William V. Tamborlane United States
David B. Dunger United Kingdom
Anne L. Peters United States
Denis Daneman Canada
Francine Kaufman United States
Sharon Saydah United States
Giuseppina Imperatore United States View profile →
Citations per field, relative to Lori M. Laffel
Lori M. Laffel · 1×
Citations per year, relative to Lori M. Laffel
Lori M. Laffel · 1×

Countries citing papers authored by Lori M. Laffel

Since Specialization
Citations

This map shows the geographic impact of Lori M. Laffel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori M. Laffel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori M. Laffel more than expected).

Fields of papers citing papers by Lori M. Laffel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori M. Laffel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori M. Laffel. The network helps show where Lori M. Laffel may publish in the future.

Co-authorship network of co-authors of Lori M. Laffel

This figure shows the co-authorship network connecting the top 25 collaborators of Lori M. Laffel. A scholar is included among the top collaborators of Lori M. Laffel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori M. Laffel. Lori M. Laffel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Dietary Patterns for Weight and Glycemic Management in Persons With Type 1 Diabetes: A Meta-analysis of Clinical Trials
2025 ·The Journal of Clinical Endocrinology & Metabolism ·Daria Igudesman, Laura M. Nally, Alyssa Grimshaw, Craig G. Gunderson, (unknown), Laura M. Jacobsen, Mustafa Tosur, Peter A. Gottlieb, Irl B. Hirsch, Lori M. Laffel, Jennifer L. Sherr, (unknown), Richard E. Pratley
2
2
Practical Considerations and Implementation of Automated Insulin Delivery Systems
2025 ·Journal of Diabetes Science and Technology ·Laurel H. Messer, Gregory P. Forlenza, Linda Gonder‐Frederick, Korey K. Hood, Osagie Ebekozien, Katharine Barnard‐Kelly, Lori M. Laffel, Jennifer L. Sherr, Rayhan Lal, Stuart A. Weinzimer
1
3
Lower Independent Self-Care Readiness Persists Over Time in Teens With Type 1 Diabetes and Executive Function Challenges
2024 ·The Journal of Clinical Endocrinology & Metabolism ·(unknown), Liane J. Tinsley, Lisa K. Volkening, Lori M. Laffel
0
4
Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial
2023 ·Pediatric Diabetes ·Laurel H. Messer, (unknown), Kellee M. Miller, Mark A. Clements, Daniel J. DeSalvo, Jennifer L. Sherr, Ruth S. Weinstock, Korey K. Hood, Lori M. Laffel
1
5
Psychosocial Outcomes with the Omnipod® 5 Automated Insulin Delivery System in Children and Adolescents with Type 1 Diabetes and Their Caregivers
2023 ·Pediatric Diabetes ·Korey K. Hood, William H. Polonsky, Sarah A. MacLeish, Carol J. Levy, Gregory P. Forlenza, Amy Criego, Bruce A. Buckingham, Bruce W. Bode, David W. Hansen, Jennifer L. Sherr, Sue A. Brown, Daniel J. DeSalvo, Sanjeev N. Mehta, Lori M. Laffel, Anuj Bhargava, Lauren M. Huyett, Todd Vienneau, Trang T. Ly
6
6
Development and delivery of a brief family behavioral intervention to support continuous glucose monitor use in young children with type 1 diabetes
2022 ·Pediatric Diabetes ·Marisa E. Hilliard, Persis Commissariat, Lauren Kanapka, Lori M. Laffel, Wendy Levy, Kara R. Harrington, Barbara J. Anderson, Kellee M. Miller, Linda A. DiMeglio
6
7
Assessing Incorporation of Type 1 Diabetes Into Identity: Validation of the Accepting Diabetes and Personal Treatment (ADAPT) Survey in Teens and Young Adults
2022 ·Canadian Journal of Diabetes ·Persis Commissariat, Lisa K. Volkening, Stuart A. Weinzimer, Eyal Dassau, Lori M. Laffel
7
8
TRADUÇÃO E ADAPTAÇÃO CULTURAL DO “DIABETES EATING PROBLEM SURVEY – REVISED” PARA O BRASIL
2022 ·RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 ·Thereza Maria Magalhães Moreira, (unknown), (unknown), Helena Alves de Carvalho Sampaio, Maria Veraci Oliveira Queiroz, Lori M. Laffel
0
9
“Fear That One Day I May Not Be Able to Afford Insulin”: The Emotional Burden of Diabetes Costs During Emerging Adulthood
2022 ·Diabetes Technology & Therapeutics ·(unknown), Katherine Wentzell, Lori M. Laffel
12
10
Blood glucose monitoring (BGM) still matters for many: Associations of BGM frequency and glycemic control in youth with type 1 diabetes
2021 ·Primary care diabetes ·Rebecca Ortiz La Banca, (unknown), Lisa K. Volkening, Zijing Guo, (unknown), Lori M. Laffel
4
11
Innovative features and functionalities of an artificial pancreas system: What do youth and parents want?
2020 ·Diabetic Medicine ·Persis Commissariat, Lisa K. Volkening, Deborah Butler, Eyal Dassau, Stuart A. Weinzimer, Lori M. Laffel
4
12
Therapeutic play to teach children with type 1 diabetes insulin self‐injection: A pilot trial in a developing country
2020 ·Journal for Specialists in Pediatric Nursing ·Rebecca Ortiz La Banca, Lori M. Laffel, Lisa K. Volkening, Valéria de Cássia Sparapani, Emı́lia Campos de Carvalho, Lucila Castanheira Nascimento
5
13
Executive dysfunction is associated with poorer health-related quality of life in adolescents with type 1 diabetes: differences by sex
2020 ·Quality of Life Research ·Eveline R. Goethals, Lisa K. Volkening, Lori M. Laffel
7
14
Commercially Available Insulin Products Demonstrate Stability Throughout the Cold Supply Chain Across the U.S.
2020 ·Diabetes Care ·Timothy J. Garrett, (unknown), Eoin P. Quinlivan, Lynn Ang, Irl B. Hirsch, Lori M. Laffel, Massimo Pietropaolo, Michael J. Haller, Mark A. Atkinson
3
15
Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial
2019 ·Diabetes Care ·Bruce W. Bode, Violeta Iotova, М. А. Коваренко, Lori M. Laffel, Paturi Vishnupriya Rao, Srikanth Deenadayalan, Magnus Ekelund, (unknown), Thomas Danne
46
16
“I'm essentially his pancreas”: Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes
2019 ·Pediatric Diabetes ·Persis Commissariat, Kara R. Harrington, (unknown), Kellee M. Miller, Marisa E. Hilliard, Michelle Van Name, Daniel J. DeSalvo, William V. Tamborlane, Barbara J. Anderson, Linda A. DiMeglio, Lori M. Laffel
66
17
Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes
2018 ·PMC ·Michelle Van Name, Marisa E. Hilliard, Claire T. Boyle, Kellee M. Miller, Daniel J. DeSalvo, Barbara J. Anderson, Lori M. Laffel, Stéphanie Woerner, Linda A. DiMeglio, William V. Tamborlane
4
18
Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes
2017 ·Pediatric Diabetes ·William V. Tamborlane, Lori M. Laffel, Jacques Weill, (unknown), Dietmar Neubacher, Silke Retlich, (unknown), Cornelia E. Hoesl, Stefan Kaspers, Jan Marquard
16
19
Use of Commonly Available Technologies for Diabetes Information and Self-Management Among Adolescents With Type 1 Diabetes and Their Parents: A Web-Based Survey Study
2015 ·Interactive Journal of Medical Research ·Sarah E. Vaala, Korey K. Hood, Lori M. Laffel, (unknown), (unknown), Shelagh A. Mulvaney
40
20
Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial.
2006 ·PubMed ·Elaine Moreland, Lisa K. Volkening, (unknown), (unknown), Barbara J. Anderson, Lori M. Laffel
51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppina Imperatore Breakdown of academic impact, for papers by David M. Maahs Breakdown of academic impact, for papers by Lawrence M. Dolan Breakdown of academic impact, for papers by Reinhard W. Holl Breakdown of academic impact, for papers by William V. Tamborlane Breakdown of academic impact, for papers by David B. Dunger Breakdown of academic impact, for papers by Anne L. Peters Breakdown of academic impact, for papers by Denis Daneman Breakdown of academic impact, for papers by Francine Kaufman Breakdown of academic impact, for papers by Sharon Saydah
Rankless by CCL
2026